Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18325181rdf:typepubmed:Citationlld:pubmed
pubmed-article:18325181lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:18325181lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:18325181lifeskim:mentionsumls-concept:C1704417lld:lifeskim
pubmed-article:18325181lifeskim:mentionsumls-concept:C0599882lld:lifeskim
pubmed-article:18325181lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:18325181pubmed:issuePt 2lld:pubmed
pubmed-article:18325181pubmed:dateCreated2008-3-7lld:pubmed
pubmed-article:18325181pubmed:abstractTextFamilial ligand-defective apolipoprotein B-100 (FDB) is characterized by elevated plasma concentrations of LDL-cholesterol and apolipoprotein (apo) B, normal triglyceride and HDL-cholesterol levels, the presence of tendon xanthomas, and premature coronary artery disease. FDB cannot be clinically distinguished from heterozygous LDL-receptor-defective familial hypercholesterolaemia (FH) without genetic testing.lld:pubmed
pubmed-article:18325181pubmed:languageenglld:pubmed
pubmed-article:18325181pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18325181pubmed:citationSubsetIMlld:pubmed
pubmed-article:18325181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18325181pubmed:statusMEDLINElld:pubmed
pubmed-article:18325181pubmed:monthMarlld:pubmed
pubmed-article:18325181pubmed:issn0004-5632lld:pubmed
pubmed-article:18325181pubmed:authorpubmed-author:DefescheJoep...lld:pubmed
pubmed-article:18325181pubmed:authorpubmed-author:BurnettJohn...lld:pubmed
pubmed-article:18325181pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:18325181pubmed:authorpubmed-author:HooperAmanda...lld:pubmed
pubmed-article:18325181pubmed:authorpubmed-author:LiyanageKhema...lld:pubmed
pubmed-article:18325181pubmed:issnTypePrintlld:pubmed
pubmed-article:18325181pubmed:volume45lld:pubmed
pubmed-article:18325181pubmed:ownerNLMlld:pubmed
pubmed-article:18325181pubmed:authorsCompleteYlld:pubmed
pubmed-article:18325181pubmed:pagination170-6lld:pubmed
pubmed-article:18325181pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:meshHeadingpubmed-meshheading:18325181...lld:pubmed
pubmed-article:18325181pubmed:year2008lld:pubmed
pubmed-article:18325181pubmed:articleTitleHigh-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations.lld:pubmed
pubmed-article:18325181pubmed:affiliationSchool of Surgery and Pathology, University of Western Australia, Perth, Australia.lld:pubmed
pubmed-article:18325181pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18325181pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18325181pubmed:publicationTypeEvaluation Studieslld:pubmed